Yung-Ho Hsu - Search Results

Year	Number of Results
2002	1
2003	3
2004	1
2005	3
2006	6
2007	5
2008	1
2009	2
2010	1
2011	2
2012	8
2013	5
2014	5
2015	5
2016	13
2017	7
2018	10
2019	16
2020	12
2021	11
2022	1

1

Bone loss in chronic kidney disease: Quantity or quality?

Zheng CM, Zheng JQ, Wu CC, Lu CL, Shyu JF, Yung-Ho H, Wu MY, Chiu IJ, Wang YH, Lin YF, Lu KC. Zheng CM, et al. Among authors: yung ho h. Bone. 2016 Jun;87:57-70. doi: 10.1016/j.bone.2016.03.017. Epub 2016 Apr 2. Bone. 2016. PMID: 27049042 Review.

2

Current Strategies in Assessment of Nanotoxicity: Alternatives to In Vivo Animal Testing.

Huang HJ, Lee YH, Hsu YH, Liao CT, Lin YF, Chiu HW. Huang HJ, et al. Among authors: hsu yh. Int J Mol Sci. 2021 Apr 19;22(8):4216. doi: 10.3390/ijms22084216. Int J Mol Sci. 2021. PMID: 33921715 Free PMC article. Review.

3

3-Methylcholanthrene/Aryl-Hydrocarbon Receptor-Mediated Hypertension Through eNOS Inactivation.

Chang CC, Hsu YH, Chou HC, Lee YG, Juan SH. Chang CC, et al. Among authors: hsu yh. J Cell Physiol. 2017 May;232(5):1020-1029. doi: 10.1002/jcp.25497. Epub 2016 Aug 10. J Cell Physiol. 2017. PMID: 27442426

4

Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.

Wu MY, Chang NC, Su CL, Hsu YH, Chen TW, Lin YF, Wu CH, Tam KW. Wu MY, et al. Among authors: hsu yh. J Crit Care. 2014 Feb;29(1):2-9. doi: 10.1016/j.jcrc.2013.10.009. Epub 2013 Oct 29. J Crit Care. 2014. PMID: 24331943 Review.

5

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.

Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Wu MY, et al. Among authors: hsu yh. Am J Kidney Dis. 2012 Jun;59(6):810-8. doi: 10.1053/j.ajkd.2011.11.030. Epub 2012 Jan 5. Am J Kidney Dis. 2012. PMID: 22226564 Review.

6

Influence of intradialytic systolic blood pressure changes on arteriovenous access thrombosis in maintenance hemodialysis patients.

Zheng CM, Chiu YP, Hou YC, Liu YM, Wu MS, Lin YF, Lo YL, Lu KC, Hsu YH, Wang YH. Zheng CM, et al. Among authors: hsu yh. Int J Clin Pract. 2021 Mar;75(3):e13799. doi: 10.1111/ijcp.13799. Epub 2020 Nov 20. Int J Clin Pract. 2021. PMID: 33113231

7

Achievements and challenges in chronic kidney disease care in Taiwan.

Hsu CC, Hsu YH, Wu MS, Hwang SJ. Hsu CC, et al. Among authors: hsu yh. J Formos Med Assoc. 2022 Jan 8:S0929-6646(21)00581-7. doi: 10.1016/j.jfma.2021.12.016. Online ahead of print. J Formos Med Assoc. 2022. PMID: 35016834 No abstract available.

8

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients.

Liao CT, Zheng CM, Lin YC, Wu MY, Lin YF, Hsu YH, Hsu CC, Wu MS. Liao CT, et al. Among authors: hsu yh. Sci Rep. 2021 Jan 13;11(1):1171. doi: 10.1038/s41598-020-80938-2. Sci Rep. 2021. PMID: 33441921 Free PMC article.

9

Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.

Chang TI, Chen CH, Hsieh HL, Chen CY, Hsu SC, Cheng HS, Huang WC, Sue YM, Hsu YH, Lin FY, Shih CM, Lin SJ, Huang PH, Liu CT. Chang TI, et al. Among authors: hsu yh. Sci Rep. 2020 Jul 22;10(1):12135. doi: 10.1038/s41598-020-69019-6. Sci Rep. 2020. PMID: 32699337 Free PMC article.

10

The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.

Wu MY, Hsiang HF, Wong CS, Yao MS, Li YW, Hsiang CY, Bai CH, Hsu YH, Lin YF, Tam KW. Wu MY, et al. Among authors: hsu yh. Int Urol Nephrol. 2013 Oct;45(5):1309-18. doi: 10.1007/s11255-012-0363-1. Epub 2013 Jan 3. Int Urol Nephrol. 2013. PMID: 23283594 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results